Johan Sedihn, who is currently executive vice president of oncology, has been appointed as CEO. Replacing Sedihn is Bill Yaeger, who comes to Elekta after serving as CEO of Oncology Services International.
In other moves, Elekta said that Olof Sandén, executive vice president and head of the Europe, Africa, Latin America, and the Middle East region, has decided to leave Elekta. President and CEO Tomas Puusepp will be assuming his responsibilities on an interim basis, according to the company.
Elekta has also promoted John Lapré, vice president of research and development for brachytherapy, to executive vice president of brachytherapy. Lapré will succeed Jos Lamers, who has elected to leave the company, Elekta said.
Elekta adds linac to Indian cancer center, May 2, 2012
Elekta reports first Agility treatments, April 19, 2012
Elekta wins CE Mark for collimator, April 2, 2012
Elekta wins CE Mark for radiation therapy couchtop, March 28, 2012
Elekta promotes China market milestones, March 22, 2012
Copyright © 2012 AuntMinnieEurope.com